Patients can benefit both financially and clinically by enrolling in ongoing clinical trials, said Eric Lander, MD.

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

Widespread noncompliance with federal cost-sharing rules exists, particularly impacting Medicare beneficiaries and ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

It's a critical time to spotlight the dire health disparities affecting Black Americans, from premature deaths to maternal ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

A prior settlement of $6 billion was rejected because it would have shielded the Sackler family from lawsuits even from ...